Finance

Senarai
1093:HKG
CSPC Pharmaceutical Group Ltd
HK$8.88
+0.17%
(+0.015) 1H
16 Okt, 4:08:14 PTG GMT+8  ·   HKD
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk 1093...
Buka
HK$9.09
Tinggi
HK$9.19
Rendah
HK$8.77
Permodalan Pasaran
102.26B
Purata volum
76.68J
Volum
72.90J
Dividen
3.72%
Dividen suku tahunan
HK$0.08
Tarikh tanpa dividen
20 Okt 2026
Nisbah H/P
11.64
tgi 52 mgu
HK$10.96
rdh 52 mgu
HK$6.53
EPS
HK$0.76
Syer tertunggak
11.52B
Bilangan pekerja
19K
Buka
HK$9.09
Tinggi
HK$9.19
Rendah
HK$8.77
Permodalan Pasaran
102.26B
Purata volum
76.68J
Volum
72.90J
Dividen
3.72%
Dividen suku tahunan
HK$0.08
Tarikh tanpa dividen
20 Okt 2026
Nisbah H/P
11.64
tgi 52 mgu
HK$10.96
rdh 52 mgu
HK$6.53
EPS
HK$0.76
Syer tertunggak
11.52B
Bilangan pekerja
19K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Profil
CSPC Pharmaceutical Group researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province. CSPC produces both active pharmaceutical ingredient and formulations. API products include penicillin, cefalosporins, synthetic vitamins, caffeine and ranitidine. Formulations include antibiotics, butylphthalide and analgesics, in addition to nearly 1,000 other products. CSPC's 15,000 employees are divided among more than ten subsidiaries, including CSPC Zhongrun, Weisheng, Zhongnuo and NBP. CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises. One subsidiary, China Pharmaceutical Group Co., Ltd is based in Hong Kong. It is listed on the Hang Seng China-Affiliated Corporations Index. In 2003 and 2004, China Pharma was listed as one of 100 excellent listed companies with turnover less than $1 billion. CSPC Pharma is recognized as one of China's "500 Most Valuable Chinese Brands" and "Top 500 Chinese Enterprises." Wikipedia
Perihal CSPC Pharmaceutical Group Ltd
CEOZhang Cuilong
Pekerja18.6K
Diasaskan1992
Ibu pejabat-
Sektor-
Laman webcspc.com.hk
Laporan terakhir
20 Ogo 2026
Tempoh fiskal
S2 2026
- / -
Hasil / Anggaran (HKD)
14.13B / 10.11B
Panggilan persidangan pendapatan fiskal Suku Ke-2 2026
Menunggu panggilan persidangan pendapatan
Sekilas pandang
Cerapan daripada berita dan laporan terkini
Laporan sebelumnyaSemua nilai dalam HKD
Loading Previous Earnings...
Hasil
Pendapatan bersih
Semua nilai dalam CNY
Sep 2025
Dis 2025
Mac 2026
Jun 2026
Hasil
6.62B
6.11B
6.47B
12.13B
Kos barangan yang dijual
2.28B
2.11B
2.20B
2.24B
Kos hasil
2.28B
2.11B
2.20B
2.24B
Perbelanjaan penyelidikan dan pembangunan
1.50B
1.62B
1.40B
1.63B
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
1.97B
1.87B
1.89B
1.89B
Belanja kendalian
3.47B
3.49B
3.29B
3.51B
Jumlah belanja kendalian
5.75B
5.60B
5.49B
5.75B
Pendapatan kendalian
869.63J
514.71J
973.82J
6.38B
Pendapatan bukan kendalian lain
645.14J
-470.42J
181.80J
11.92J
EBT termasuk item luar biasa
1.18B
505.59J
1.13B
6.40B
EBT tidak termasuk item luar biasa
1.37B
186.56J
1.13B
6.35B
Belanja cukai pendapatan
222.47J
165.64J
243.25J
825.70J
Kadar cukai berkesan
18.78%
32.76%
21.46%
12.91%
Belanja kendalian lain
-
-
-
-
Pendapatan bersih
963.54J
370.72J
859.79J
5.23B
Margin untung bersih
14.56%
6.06%
13.30%
43.16%
Perolehan bagi setiap syer
-
-
-
-
Pendapatan faedah dan pelaburan
-
195.87J
-
91.68J
Belanja faedah
-104.94J
-6.76J
-11.01J
-2.30J
Belanja faedah bersih
-104.94J
189.12J
-11.01J
89.37J
Caj susut nilai dan pelunasan
-
-
-
-
EBITDA
1.14B
802.06J
1.26B
6.67B
Keuntungan atau kerugian daripada jualan aset
-
-
-
-
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian
Apl Google